Aligning Environmental monitoring SOP With Data Integrity, ALCOA+ and 21 CFR Part 11
Environmental monitoring plays a crucial role in ensuring the quality and integrity of the pharmaceutical manufacturing process. It involves systematically sampling and analyzing the environment where products are manufactured, stored, or tested. This is vital not just for compliance with regulatory requirements but also to secure product quality and safety. Given the significant emphasis on governance by authorities like the FDA, EMA, and MHRA, organizations must have robust Standard Operating Procedures (SOPs) that align with necessary compliance frameworks, including FDA 21 CFR Part 11 and Annex 11 of the EU GMP guidelines.
Click to read the full article.